Prevention of intraventricular haemorrhage in babies receiving artificial ventilation.
D001049:Apnea / Q000628:therapy; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000401:mortality / Q000517:prevention & control*; D002552:Cerebral Ventricles; D005164:Factor IX / Q000627:therapeutic use; D005167:Factor VII / Q000627:therapeutic use; D005170:Factor X / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006819:Hyaline Membrane Disease / Q000628:therapy; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D008297:Male; D011175:Positive-Pressure Respiration / Q000009:adverse effects*; D011516:Prothrombin / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D005167:Factor VII; D011516:Prothrombin; D005164:Factor IX; D005170:Factor X